Marijo Bilušić

4.0k total citations
113 papers, 2.0k citations indexed

About

Marijo Bilušić is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Marijo Bilušić has authored 113 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 55 papers in Pulmonary and Respiratory Medicine and 37 papers in Immunology. Recurrent topics in Marijo Bilušić's work include Cancer Immunotherapy and Biomarkers (45 papers), Prostate Cancer Treatment and Research (39 papers) and Immunotherapy and Immune Responses (34 papers). Marijo Bilušić is often cited by papers focused on Cancer Immunotherapy and Biomarkers (45 papers), Prostate Cancer Treatment and Research (39 papers) and Immunotherapy and Immune Responses (34 papers). Marijo Bilušić collaborates with scholars based in United States, Croatia and New Zealand. Marijo Bilušić's co-authors include James L. Gulley, Ravi A. Madan, Jeffrey Schlom, Christopher R. Heery, Renee N. Donahue, Margaret E. Gatti‐Mays, Jennifer L. Marté, Julius Strauss, Julie Collins and Fatima Karzai and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marijo Bilušić

106 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marijo Bilušić United States	22	1.2k	889	512	471	190	113	2.0k
Laura Pala Italy	18	1.3k 1.1×	525 0.6×	523 1.0×	348 0.7×	270 1.4×	66	2.1k
Roisin E. O’Cearbhaill United States	25	1.2k 1.0×	446 0.5×	348 0.7×	471 1.0×	472 2.5×	174	2.4k
Hirohito Kobayashi Japan	28	1.1k 1.0×	1.1k 1.2×	1.0k 2.0×	593 1.3×	599 3.2×	132	2.8k
Jun Zhu China	24	1.4k 1.2×	552 0.6×	213 0.4×	479 1.0×	129 0.7×	177	2.5k
Ruth Vera Spain	24	1.3k 1.1×	347 0.4×	394 0.8×	252 0.5×	357 1.9×	102	1.8k
David Peace United States	27	767 0.7×	864 1.0×	181 0.4×	422 0.9×	118 0.6×	79	2.1k
Francisco Ayala Spain	24	774 0.7×	475 0.5×	240 0.5×	492 1.0×	287 1.5×	105	2.0k
A.M.M. Eggermont Netherlands	26	1.2k 1.1×	602 0.7×	482 0.9×	700 1.5×	300 1.6×	94	2.1k
Ammar Sukari United States	24	1.5k 1.3×	381 0.4×	635 1.2×	640 1.4×	311 1.6×	118	2.3k
Jacques‐Olivier Bay France	25	721 0.6×	391 0.4×	538 1.1×	702 1.5×	121 0.6×	151	2.4k

Countries citing papers authored by Marijo Bilušić

Since Specialization

Citations

This map shows the geographic impact of Marijo Bilušić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijo Bilušić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijo Bilušić more than expected).

Fields of papers citing papers by Marijo Bilušić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijo Bilušić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijo Bilušić. The network helps show where Marijo Bilušić may publish in the future.

Co-authorship network of co-authors of Marijo Bilušić

This figure shows the co-authorship network connecting the top 25 collaborators of Marijo Bilušić. A scholar is included among the top collaborators of Marijo Bilušić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijo Bilušić. Marijo Bilušić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simon, Nicholas I., Daniel M. Girardi, Lisa Ley, et al.. (2024). A phase II multicenter study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors (E-VIRTUE).. Journal of Clinical Oncology. 42(16_suppl). TPS4628–TPS4628.

Zhang, Ling, Clara I. Troccoli, Erin A. Jackson, et al.. (2024). Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer. Cancer Research. 85(1). 134–153. 2 indexed citations

Gatti‐Mays, Margaret E., Nicholas Tschernia, Julius Strauss, et al.. (2023). A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors. The Oncologist. 28(4). 364–e217. 9 indexed citations

Gandhy, Shruti U., Fatima Karzai, Marijo Bilušić, et al.. (2023). Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide. European Urology Oncology. 7(4). 735–741. 1 indexed citations

Bilušić, Marijo, et al.. (2022). Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?. Journal of Clinical Investigation. 132(23). 5 indexed citations

Redman, Jason M., Benjamin A. Weinberg, Renee N. Donahue, et al.. (2022). A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer. The Oncologist. 27(3). 198–209. 30 indexed citations

Bilušić, Marijo, Renee N. Donahue, Susan Wróblewski, et al.. (2022). A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate Cancer and Prostatic Diseases. 25(4). 735–740. 17 indexed citations

Rich, Benjamin, Benjamin Spieler, Brandon A. Mahal, et al.. (2022). Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 114(4). 718–724. 4 indexed citations

Hoke, Austin T.K., Michelle R. Padget, Kellsye P. Fabian, et al.. (2021). Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells. Cancer Research Communications. 1(3). 127–139. 14 indexed citations

10.

Bilušić, Marijo, Sheri McMahon, Ravi A. Madan, et al.. (2021). Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal for ImmunoTherapy of Cancer. 9(3). e002374–e002374. 43 indexed citations

11.

Strauss, Julius, Margaret E. Gatti‐Mays, Byoung Chul Cho, et al.. (2021). 957O Long-term follow-up of patients (pts) with human papillomavirus (HPV)–associated malignancies treated with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1. Annals of Oncology. 32. S829–S829. 5 indexed citations

12.

Bilušić, Marijo & James L. Gulley. (2020). Neoadjuvant Immunotherapy: An Evolving Paradigm Shift?. JNCI Journal of the National Cancer Institute. 113(7). 799–800. 8 indexed citations

13.

Chau, Vincent & Marijo Bilušić. (2020). <p>Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date</p>. Cancer Management and Research. Volume 12. 7321–7330. 27 indexed citations

14.

Chau, Vincent & Marijo Bilušić. (2020). Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date. SHILAP Revista de lepidopterología. 2 indexed citations

15.

Madan, Ravi A., Susan F. Slovin, Lauren C. Harshman, et al.. (2020). 681P Clinical and immune responses to immunotherapy in biochemically recurrent (non-metastatic castration sensitive) prostate cancer (BCRpc). Annals of Oncology. 31. S542–S542. 1 indexed citations

16.

Strauss, Julius, Christopher R. Heery, Joseph W. Kim, et al.. (2018). First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors. Clinical Cancer Research. 25(1). 99–109. 116 indexed citations

17.

Ghatalia, Pooja, Samuel Litwin, Eric M. Horwitz, et al.. (2016). Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clinical Genitourinary Cancer. 15(3). e337–e343. 16 indexed citations

18.

Madan, Ravi A., Marijo Bilušić, Christopher R. Heery, Jeffrey Schlom, & James L. Gulley. (2012). Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines. Seminars in Oncology. 39(3). 296–304. 64 indexed citations

19.

Bilušić, Marijo, Christopher R. Heery, & Ravi A. Madan. (2011). Immunotherapy in prostate cancer: Emerging strategies against a formidable foe. Vaccine. 29(38). 6485–6497. 17 indexed citations

20.

Bilušić, Marijo, Carol Moreno, Michael Tschannen, et al.. (2008). Genetically Hypertensive Brown Norway Congenic Rat Strains Suggest Intermediate Traits Underlying Genetic Hypertension. Croatian Medical Journal. 49(5). 586–599. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact